Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.2028 | 0.2028 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0074 | 0.2175 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0074 | 0.2175 | 0.6354 |
Loa Loa (eye worm) | hypothetical protein | 0.0306 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.135 | 0.135 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.135 | 0.135 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.135 | 0.135 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2028 | 0.5925 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0111 | 0.3423 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.135 | 0.135 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.135 | 0.3943 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0111 | 0.3423 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2028 | 0.5925 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0111 | 0.3423 | 0.3423 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2028 | 0.5925 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0111 | 0.3423 | 0.3423 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.2028 | 0.2028 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.135 | 0.135 |
Brugia malayi | Melibiase family protein | 0.0074 | 0.2175 | 0.2175 |
Brugia malayi | RNA binding protein | 0.007 | 0.2028 | 0.2028 |
Echinococcus multilocularis | muscleblind protein | 0.0306 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.007 | 0.2028 | 0.2028 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0111 | 0.3423 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.135 | 0.3943 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.2028 | 0.2028 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0074 | 0.2175 | 0.6354 |
Toxoplasma gondii | melibiase subfamily protein | 0.0111 | 0.3423 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0306 | 1 | 1 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0111 | 0.3423 | 0.3423 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2028 | 0.5925 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0016 | 0.0207 | 0.0605 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.135 | 0.3943 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2028 | 0.5925 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.135 | 0.135 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.2028 | 0.2028 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.2028 | 0.2028 |
Loa Loa (eye worm) | hypothetical protein | 0.0306 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.2175 | 0.2175 |
Echinococcus granulosus | muscleblind protein | 0.0306 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0111 | 0.3423 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.2028 | 0.2028 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.